BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 6965420)

  • 1. Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung.
    Hunninghake GW; Gadek JE; Young RC; Kawanami O; Ferrans VJ; Crystal RG
    N Engl J Med; 1980 Mar; 302(11):594-8. PubMed ID: 6965420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis.
    Hance AJ; Douches S; Winchester RJ; Ferrans VJ; Crystal RG
    J Immunol; 1985 Jan; 134(1):284-92. PubMed ID: 3964815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current aspects of pulmonary granulomatosis].
    Moisescu V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1986; 35(3):193-202. PubMed ID: 3027856
    [No Abstract]   [Full Text] [Related]  

  • 4. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.
    Hunninghake GW
    Am Rev Respir Dis; 1984 Apr; 129(4):569-72. PubMed ID: 6608889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes.
    Hunninghake GW; Crystal RG
    J Clin Invest; 1981 Jan; 67(1):86-92. PubMed ID: 6969734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation.
    Lem VM; Lipscomb MF; Weissler JC; Nunez G; Ball EJ; Stastny P; Toews GB
    J Immunol; 1985 Sep; 135(3):1766-71. PubMed ID: 3874905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage inflammatory protein-1 alpha expression in interstitial lung disease.
    Standiford TJ; Rolfe MW; Kunkel SL; Lynch JP; Burdick MD; Gilbert AR; Orringer MB; Whyte RI; Strieter RM
    J Immunol; 1993 Sep; 151(5):2852-63. PubMed ID: 8360496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIH conference. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes.
    Ann Intern Med; 1981 Jan; 94(1):73-94. PubMed ID: 7004303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of the immune response in sarcoidosis.
    Hunninghake GW; Fulmer JD; Young RC; Gadek JE; Crystal RG
    Am Rev Respir Dis; 1979 Jul; 120(1):49-57. PubMed ID: 313729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.
    Venet A; Hance AJ; Saltini C; Robinson BW; Crystal RG
    J Clin Invest; 1985 Jan; 75(1):293-301. PubMed ID: 3871200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T lymphocyte motility toward IL-1 in patients with interstitial lung diseases.
    Htin-Aung
    Bull Chest Dis Res Inst Kyoto Univ; 1990 Mar; 23(1-2):38-47. PubMed ID: 2134043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of peripheral blood monocytes in pulmonary sarcoidosis.
    Rømer FK; Christiansen SE; Kragballe K; Herlin T; Madsen M
    Clin Exp Immunol; 1984 Nov; 58(2):357-63. PubMed ID: 6094058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of alveolar macrophage- and lung T cell-derived mediators in pulmonary sarcoidosis.
    Hunninghake GW
    Ann N Y Acad Sci; 1986; 465():82-90. PubMed ID: 2425678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
    Robinson BW; McLemore TL; Crystal RG
    J Clin Invest; 1985 May; 75(5):1488-95. PubMed ID: 3923038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helper T-lymphocytes in pulmonary sarcoidosis. Functional analysis of a lung T-cell subpopulation in patients with active disease.
    Rossi GA; Sacco O; Cosulich E; Risso A; Balbi B; Ravazzoni C
    Am Rev Respir Dis; 1986 Jun; 133(6):1086-90. PubMed ID: 2940949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions.
    Agostini C; Cassatella M; Zambello R; Trentin L; Gasperini S; Perin A; Piazza F; Siviero M; Facco M; Dziejman M; Chilosi M; Qin S; Luster AD; Semenzato G
    J Immunol; 1998 Dec; 161(11):6413-20. PubMed ID: 9834133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis.
    Konishi K; Moller DR; Saltini C; Kirby M; Crystal RG
    J Clin Invest; 1988 Sep; 82(3):775-81. PubMed ID: 3138285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered immunological reactivity in alveolar macrophages from patients with sarcoidosis.
    Gallagher RB; Guckian M; van Breda A; Odlum C; Fitzgerald MX; Feighery C
    Eur Respir J; 1988 Feb; 1(2):153-60. PubMed ID: 2966072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukins in pulmonary sarcoidosis. Dissociative correlations of lung interleukins 1 and 2 with the intensity of alveolitis.
    Yamaguchi E; Okazaki N; Tsuneta Y; Abe S; Terai T; Kawakami Y
    Am Rev Respir Dis; 1988 Sep; 138(3):645-51. PubMed ID: 3264477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity.
    Hunninghake GW; Crystal RG
    N Engl J Med; 1981 Aug; 305(8):429-34. PubMed ID: 6454846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.